Research map: The predictive value of inflammatory biomarkers for major pathological response in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy and its association with the immune-related tumor microenvironment: a multi-center study

Back to the article

Papers in this map

  1. limma powers differential expression analyses for RNA-sequencing and microarray studies · Matthew E. Ritchie · 2015 · 44581 citations · Cited by this paper
  2. Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy · Qilin Huai · 2023 · 97 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer · Leena Gandhi · 2018 · 6765 citations · Cited by this paper
  5. Association of systemic inflammatory markers and tertiary lymphoid structure with pathological complete response in gastric cancer patients receiving preoperative treatment: a retrospective cohort study · Yingying Wu · 2023 · 34 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade · Pornpimol Charoentong · 2017 · 5479 citations · Cited by this paper
  8. Monocyte-related markers as predictors of immune checkpoint inhibitor efficacy and immune-related adverse events: a systematic review and meta-analysis · Aiarpi A. Ezdoglian · 2025 · 25 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer · Peter Goldstraw · 2016 · 4750 citations · Cited by this paper
  11. Exploring the prognostic impact of absolute lymphocyte count in patients treated with immune-checkpoint inhibitors · Michael R. Conroy · 2024 · 23 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. B cells and tertiary lymphoid structures promote immunotherapy response · Beth Ann Helmink · 2020 · 2815 citations · Cited by this paper
  14. Immunotherapy for early-stage non-small cell lung cancer: A system review · Jingyi Gao · 2023 · 18 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial · Mariano Provencio · 2020 · 855 citations · Cited by this paper
  17. The association of systemic immune-inflammation index with incident breast cancer and all-cause mortality: evidence from a large population-based study · Li J. Yu · 2025 · 14 citations · Cites this paper
  18. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  19. How to develop a more accurate risk prediction model when there are few events · Menelaos Pavlou · 2015 · 692 citations · Cited by this paper
  20. Predictive role of blood-based indicators in neuromyelitis optica spectrum disorders · Xiqin Fang · 2023 · 13 citations · Cites this paper
  21. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  22. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer · Stephen Joseph Bagley · 2017 · 539 citations · Cited by this paper
  23. Association of early immune-related adverse events with treatment efficacy of neoadjuvant Toripalimab in resectable advanced non-small cell lung cancer · Ye Tao · 2023 · 13 citations · Cites this paper
  24. The Predictive Value of Neutrophil‐To‐Lymphocyte Ratio ( NLR ) for Response to Neoadjuvant Immunochemotherapy in Resectable IIA – IIIB Non‐Small Cell Lung Cancer in Real‐World Practice · 2026 · Related
  25. SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial · Sacha I. Rothschild · 2021 · 348 citations · Cited by this paper
  26. Predictive value of peripheral blood biomarkers in patients with non-small-cell lung cancer responding to anti-PD-1-based treatment · Shu Su · 2024 · 13 citations · Cites this paper
  27. VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer · 2026 · Related
  28. Untitled · Cited by this paper
  29. Chemoimmunotherapy synergism: mechanisms and clinical applications · Rahaman Shaik · 2025 · 13 citations · Cites this paper
  30. Untitled · Cited by this paper
  31. Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy · Carlo Putzu · 2024 · 10 citations · Cites this paper
  32. Untitled · Cited by this paper
  33. Variation of peripheral blood-based biomarkers for response of anti-PD-1 immunotherapy in non-small-cell lung cancer · Xiaoming Wang · 2024 · 9 citations · Cites this paper
  34. Untitled · Cited by this paper
  35. Peripheral CD8+PD-1+ T cells as novel biomarker for neoadjuvant chemoimmunotherapy in humanized mice of non-small cell lung cancer · Wenwen Guo · 2024 · 9 citations · Cites this paper
  36. Untitled · Cited by this paper
  37. Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review · Kyoichi Kaira · 2024 · 8 citations · Cites this paper
  38. Untitled · Cited by this paper
  39. Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patients · Mohammadreza Azimi · 2024 · 7 citations · Cites this paper

Source: OpenAlex (CC0)